EIN: 88-3812342 · Chapel Hill, NC
READDI, the Rapidly Emerging Antiviral Drug Development Initiative, is a nonprofit biotechnology organization founded by virologists from the University of North Carolina at Chapel Hill. Dedicated to preventing global catastrophes caused by viruses, READDI focuses on developing broad-spectrum antiviral drugs that can be deployed at the first signs of future pandemics.
With over $96 million invested in 30 active projects, READDI collaborates with 40 global partners to enhance pandemic preparedness. The organization plays a pivotal role in the 100 Days Mission, a G7 initiative aimed at ensuring rapid responses to viral threats.
Your donation to READDI supports the development of essential antiviral drugs that can save lives during future pandemics. By contributing, you help ensure that effective treatments are available to everyone, everywhere, at the onset of viral outbreaks.
Join the fight against pandemics by donating cryptocurrency or cash to READDI. Your support is crucial in developing the antiviral solutions needed for a healthier, safer world.
Do you represent Rapidly Emerging Antiviral Drug Development Initiative? Sign up and claim this page to customize it and gain access to our dashboard. Learn More.